Daniel D. Miller

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Rizwan Romee, Sarah Cooley, Melissa M. Berrien-Elliott et al. · Blood · 2018 · 407 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +9

Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole

Edward W. Cowen, Josephine Nguyen, Daniel D. Miller et al. · Journal of the American Academy of Dermatology · 2009 · 244 citations

Medicine, Dermatology, Pediatrics +14

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States

Robert G. Micheletti, Zelma C. Chiesa Fuxench, Megan H. Noe et al. · Journal of Investigative Dermatology · 2018 · 137 citations · Full text

Medicine, Dermatology, Internal Medicine +6

Melanoma Associated With Long-term Voriconazole Therapy

Daniel D. Miller, Edward W. Cowen, Josephine Nguyen et al. · Archives of Dermatology · 2010 · 135 citations · Full text

Medicine, Dermatology, Pharmacology +17

Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis—ABCD-10

Megan H. Noe, Misha Rosenbach, Rebecca A. Hubbard et al. · JAMA Dermatology · 2019 · 113 citations · Full text

Pharmacy, Dermatology, Clinical Epidemiology +15